The relevance of prolonged QTc measurement to pediatric psychopharmacology

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 42, Issue 6, 2003, Pages 642-650

  Labellarte, Michael J ^a,b   Crosson, Jane E ^a   Riddle, Mark A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Div of Child and Adol Psychiatry   (United States)

Author keywords

Adverse events monitoring; Pediatric psychopharmacology; QTc prolongation; Sudden death

Indexed keywords

DESIPRAMINE; DROPERIDOL; HALOPERIDOL; IMIPRAMINE; MESORIDAZINE; MESORIDAZINE BESYLATE; PHENOTHIAZINE; PIMOZIDE; PSYCHOTROPIC AGENT; SERTINDOLE; THIORIDAZINE; ZIPRASIDONE;

DRUG APPROVAL; DRUG CONTROL; DRUG SAFETY; DRUG SCREENING; ELECTROCARDIOGRAM; FOOD AND DRUG ADMINISTRATION; HUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUBLICATION; QT PROLONGATION; REVIEW; SIDE EFFECT; SUDDEN DEATH; ADOLESCENT; CHILD; DRUG CONTRAINDICATION; ELECTROCARDIOGRAPHY; FEMALE; LONG QT SYNDROME; MALE; METHODOLOGY; PEDIATRICS; PRESCHOOL CHILD; TORSADE DES POINTES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; PEDIATRICS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; RESEARCH DESIGN; TORSADES DE POINTES;

EID: 0642281438     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CHI.0000046860.56865.25     Document Type: Article

References (76)

1. Abramowicz M (1990), Sudden death in children treated with a tricyclic antidepressant. Med Lett Drugs Ther 32:53
2. Ahnve S (1985), Correction of the QT interval for heart rate: review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 109:568-574
3. Barber MJ, Starmer CE Grant AO (1991), Blockade of cardiac sodium channels by amitripryline and diphenylhydantoin: evidence for two use-dependent binding sites. Circ Res 69:677-696
4. Bazett HC (1920), An analysis of the time-relations of electrocardiograms. Heart 7.353-370
5. Biederman J, Baldessarini RJ, Goldblatt A, Lapey KA, Doyle A, Hesslein PS (1993), A naturalistic study of 24-hour electrocardiographic findings in children and adolescents treated with desiptamine. J Am Acad Child Adolesc Psychiatry 32:805-813
6. Beiderman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A (1989), A double-blind placebo controlled study of desipramine in the treatment of ADD, II: serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903-911
7. Brugada P, Brugada J (1992), Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20:1391-1396
8. Carmeliet E, Xhonneux R, Van Glabbeek A, Reneman R (1976), Electrophysiological effects of droperidol in different cardiac tissues. Arch Pharmacol 293:57-66
9. Carrillo JA, Ramos SI, Herraiz AG et al. (1999), Pharmacokineric interaction of fluvoxamine and thioridazine in schizophrenic patients. J Clin Psychopharmacol 19:494-499
10. Cavero I, Mestre M, Guillon JM, Crumb W (2000), Drugs that prolong QT interval as an unwanted effect: assesing their likelihood of inducing hazardous cardiac dysrhythmias. Expert Opin Pharmacother 1:947-973
11. DeClerck F, Van De Water A, D'Aubioul J et al. (2002), In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity. Fundam Clin Pharmacol 16:125-140
12. DiSalvo TG, O'Gara PT (1995), Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol 18:285-290
13. Drolet B, Rousseau G, Daleau P, Cardinal R, Simard C, Turgeon J (2001), Pimozide (Orap) prolongs cardiac repolarizarion by blocking the rapid component of the delayed rectifier potassium current in native myocytes. J Cardiovasc Pharmacol Ther 6:255-260
14. Drolet B, Zhang S, Deschenes D et al. (1999), Thioridazine lengthens repolarization of cardiac myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther 288:1261-1268
15. Enyeart JJ, Dirksen RT, Sharma VK, Williford DJ, Sheu SS (1990), Antipsychotic pimozide is a potent Ca2+ channel blocker in heart. Mol Pharmacol 37:752-757
16. Fletcher SE, Case CL, Sallee FR, Hand LD, Gillette PC (1993), Prospective study of the electrocardiographic effects of imipramine in children. J Pediatr 122:652-654
17. Flockhart DA, Drici MD, Kerbusch T et al. (2000), Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. J Clin Psychopharmacol 20:317-324
18. Flockhart DA, Oesterheld JR (2000), Cytochrome P450-mediated drug interactions. Child Adolesc Psychiatr Clin N Am 9:43-76
19. Francis PD (2002), Effects of psychotropic medications on the pediatric electrocardiogram and recommended monitoring. Curr Opin Pediatr 14:224-230
20. Fridericia LS (1920), Die systolendauer im elektrokardiogramm bei normalen menschen und bie herzkranken. Acta Med Scand 53:469-486
21. Garson A (1993), How to measure the QT interval: what is normal? Am J Cardiol 72:14B-16B
22. Glassman AH, Bigger JT Jr (2001), Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 158:1774-1782
23. Goodnick PJ, Jerry J, Parra F (2002), Psychotropic drugs and the ECG: focus on the QTc interval. Expert Opin Pharmacother 3:479-498
24. Gupta S, Masand PS, Kothari AJ (2001), Cardiovascular side effects of novel antipsychotics. CNS Spectr 6:912-918
25. Gutgesell H, Atkins D, Barst R et al. (1999), AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs. J Am Acad Child Adolesc Psychiatty 38:1037-1050
26. Guy JM, Andre-Fouet X, Porte J, Bertrand M, Lamaud M, Verneyre H (1991), Torsades de pointes and prolongation of the duration of QT interval after injection of droperidol (in French). Ann Cardiol Angetol (Paris) 40:541-545
27. Haddad PM, Anderson IM (2002), Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62:1649-1671
28. Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SH (1996), Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans. Clin Pharmacol Ther 60:543-553
29. Hatta K, Takahashi T, Nakamura H et al. (2001), The association between intravenous haloperidol and prolonged QT interval. J Clin Psychopharmacol 21.257-261
30. Jo SH, Youm JB, Lee CO, Earm YE, Ho WK (2000), Blockde of the HERG human cardiac K channel by the antidepressant drug amitriptyline. Br J Pharmacol 129:1474-1480
31. Johnson A, Giuffre RM, O'Malley K (1996), ECG changes in pediatric patients on tricyclic antidepressants, desipramine, and imipramine. Can J Psychiatry 41:102-106
32. Kang J, Wang L, Cai F, Rempe D (2000), High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide. Eur J Pharmacol 392:137-140
33. Keck PE, Mcelroy SL, Arnold LM (2001), Ziprasidone: a new atypical antipsychotic. Expert Opin Pharmacother 2:1033-1042
34. Kye C, Ryan N (1995), Pharmacological treatment of child and adolescent depression. Child Adolesc Psychiatr Clin N Am 4:261-281
35. Labellarte MJ, Walkup JT, Riddle MR (1998), The new antidepressants: selective serotonin reuptake inhibitors. Pediatr Clin North Am 5:1137-1155
36. Lawrence KR, Nasraway SA (1997), Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy 17:531-537
37. Leonard HL, March J, Rickler KC (1997), Pharmacology of selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry 36:725-736
38. Leonard HL, Meyer MC, Swedo SE et al. (1995), Electrocardiographic changes during desipramine and clomipramine treatment in children and adolescents. J Am Acad Child Adolesc Psychiatry 34:1460-1468
39. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vettermann J (1994), Droperidol causes a dose-dependent prolongation of the QT interval. Anesth Analg 79:983-986
40. Mezzacappa E, Steingard R, Kindlon D, Saul JP, Earl F (1998), Tricyclic antidepressants and autonomic control in children and adolescents. J Am Acad Child Adolesc Psychiatry 37:52-59
41. Michalets EL, Smith LK, Van Tassel ED (1998), Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction. Ann Pharmacother 32:761-765
42. Miller MD, Porter CJ, Ackerman MJ (2001), Diagnostic accuracy of screening electrocardiograms in long QT syndrome I. Pediatrics 108:8-12
43. Moss AJ (1993), Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 72:23B-25B
44. Nau C, Seaver M, Wang SY, Wang GK (2000), Block of human heart hH1 sodium channels by amitriptyline. J Pharmacol Exp Ther 292:1015-1023
45. Neborsky R, Janowsky D, Munson E, Depry D (1981), Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol: behavioral considerations. Arch Gen Psychiatry 38:195-199
46. Oesterheld JR, Flockhart DA (2003), Pharmacokinetics II: cytochrome P450-mediated drug interactions. In: Pediatric Psyckopharmacology: Principles and Practice, Martin A, Scahill L, Charney D, Leckman J, eds. New York: Oxford University Press, pp 54-66
47. Ogata N, Narahashi T (1989), Block of sodium channels by psychotropic drugs in single guinea-pig cardiac myocytes. Br J Pharmacol 97:905-913
48. Ogata N, Nishimura M, Narahashi T (1989), Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes. J Pharmacol Expr Ther 248:605-613
49. Petit P, Blayac JP, Castelnau D, Billet J, Puech R, Poget R (1987), Use of very high doses of haloperidol in the treatment of acute psychotic episodes: clinical and pharmacokinetic analysis apropos of 15 cases. Encephale 13:127-130
50. Popli AP, Baldessarini RJ, Cole JO (1994), Interactions of selective serotonin reuprake inhibitors with tricyclic antidepressants (letter). Arch Gen Psychiatry 51:666-667
51. Popper CW, Zimnitzky B (1995), Sudden death putatively related to desipramine treatment in youth: a fifth case and a review of speculative mechanisms. J Child Adolesc Psychopharmacol 5:4
52. Preskorn S, Weller E, Weller R, Glotzbach E (1983), Plasma levels of imipramine and adverse effects in children. Am J Psychiatry 140:1332-1335
53. Puddu PE, Jouve R, Mariotti S et al. (1988), Evaluation of 10 QT prediction formulas in middle-aged men from the Seven Countries Study, emphasis on the cubic root Fridericia's equation. J Electrocardiol 21:219-229
54. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL (2000), QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355:1048-1052
55. Riddle MA, Geller B, Ryan N (1993), Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 32:792-797
56. Riddle MA, Nelson JC, Kleinman CS et al. (1991), Sudden death in children receiving Norpramin: a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30:104-108
57. Ryan ND, Puig-Antich J, Cooper T et al. (1986), Imipramine in adolescent major depression: plasma level and clinical response. Acta Psychiatr Scand 73:275-288
58. Sallee FR, Kurlan R, Goetz CG et al. (2000), Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39:292-299
59. Schroeder J, Mullin A, Elliot G et al. (1989), Cardiovascular effects of desipramine in children. J Am Acad Child Adolesc Psychiatry 28:376-379
60. Sellers EM (1979), Plasma protein displacement interactions are rarely of clinical significance. Pharmacology 18:225-227
61. Stimmel GL, Gutierrez MA, Lee V (2002), Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther 24:21-37
62. Suessbrich H, Schonherr R, Heinemann SH, Attali B, Lang F, Busch AE (1997), The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120:968-974
63. Swanson JR, Jones GR, Krasselt W, Denmark LN, Ratti F (1997), Death of two subjects due to imipramine and desipramine metabolite accumulation during chronic therapy: a review of the literature and possible mechanisms. J Forensic Sci 42:335-339
64. Terstappen GC, Pula G, Carignani C, Chen MX, Roncarati R (2001), Pharmacological characterisation of the human small conductance calcium-activated potassium channel hSK3 reveals sensitivity to tricyclic antidepressants and antipsychotic phenothiazines. Neuropharmacolegy 40:772-783
65. Teschemacher AG, Seward EP, Hancox JC, Witchel HJ (1999), Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline. Br J Pharmacol 128:479-485
66. Thorgeirsson G, Rudolph SA (1984), Diltiazem-like effect of thioridazine on the dihydropyridine binding site of the calcium channel of rat myocardial membranes. Biochem Biophys Res Commun 121:657-663
67. Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H (2001), The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QTc prolongation for assessment of risk of torsade de pointes. J Clin Pharmacol 41:1310-1318
68. Varley CK (2000), Sudden death of a child treated with imipramine: case study. J Child Adolesc Psychopharmacol 10:321-325
69. Varley CK (2001), Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications. Paediatr Drugs 3:613-627
70. Varley CK, McClellan J (1997), Case study: two additional sudden deaths with tricyclic antidepressanis. J. Am Acad Child Adolesc Psychiatry 36:390-394
71. Vincent GM, Timothy KW, Leppert M, Keating M (1992), The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Eng J Med 327:846-852
72. von Bahr C, Movin G, Nordin C et al. (1991), Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype. Clin Pharmacol Ther 49:234-240
73. Waslick BD, Walsh BT, Greenhill LL et al. (1999), Cardiovascular effects of desipramine in children and adults during exercise testing. J Am Acad Child Adolesc Psychiatry 38:179-186
74. Welch R, Chue P (2000), Antipsychotic agents and QT changes. J Psychiatry Neurosci 25:154-160
75. Wilens TE, Biederman J, Baldessarini RJ et al. (1996), Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491-1501
76. Zareba W, Moss AJ (2001), Long QTc syndrome in children. J Electrocardiol 34(suppl):167-171